Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

  • 00:58

    Immuno-Oncology Drug Development: Challenges & Next Steps

    in Science

    PharmaTalk Radio's Valerie Bowling welcomes Immuno-Oncology 360° Co-Chair James Gulley, MD, PhD, National Cancer Institute as he leads a discussion with fellow Co-Chair, Axel Hoos, MD, PhD, GlaxoSmithKline. Together they discuss what's currently happening in Immuno-Oncology and its impact on how cancer is being treated. They cover the latest challenges and next steps. More specifically they also address:

    Ipilumumab/Nivo/Pembro challenges
    What can we learn from the development of sipuleucel-T that may be applicable for other therapeutic vaccines?
    Challenges with the following modalities: Checkpoints, Oncolytic Virus', Adoptive T-Cells, Cancer Vaccines
    The more interesting agents in late stage development now in immunotherapy and its promise
    Immune related adverse events
    Adoptive cellular therapies, what is the most promising?
    Will IO become backbone therapies for cancer?
    What's the next set of assets that are going to come out?
    Promises in combination therapies?
    What can we expect next?


    James Gulley, MD, PhD
    Head, Immunotherapy Section, Director, Medical Oncology Service, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute

    Axel Hoos, MD, PhD, VP, Oncology R&D, GlaxoSmithKline

    The Immuno-Oncology 360° conference is scheduled for February 2-3, 2016  at the New York Academy of Medicine in NYC. For more information, please visit www.theconferenceforum.org.

  • 00:34

    This Week in Oncology | Where Does the Oncology ACO Fit?

    in Health

    On the Wednesday, November 28th, 2012 broadcast at 1:30PM Pacific/4:30PM Eastern our special guest is Ronald Barkley, MS, JD, President, Cancer Center Business Development Group, and Partner, TRG Healthcare.   Ron recently published a piece titled: The Rapidly Evolving ACO World, which we featured at JustOncology.com.The thrust of the piece centered on the growth of Oncology ACOs or accountable care collaborations like medical homes and value based payment arrangements, in spite of CMS' decision to authorize oncologists as organizers of onology based ACOs.    Of particular note was the significant impact of a managed oncology service/ACO on the projected savings to be generated in the Medicare Shared Savings Program. In fact, if one applies the expected 10% savings threshold to realized if best practices of an oncology medical home where imbued in the ACO. Those savings equaled the total expected to be generated for the entire expected savings from primary care.   For additional context, see: Where Does Oncology Fit in the Scheme of Accountable Care?   Join us!        

  • 00:38

    This Week in Oncology: PatientsWithPower

    in Health

    On a special edition of this Week in Oncology, at 11AM Pacific/2PM Eastern on Friday, June 28th, 2013 we chat with Bill Guthrie, CEO and Co-founder of PatientsWithPower.
    The PatientsWithPower team submitted the their cancer patient empowerment app in the Office of the National Coordinator for HealthIT (ONC) and National Cancer Institute (NCI) jointly sponsored 'Crowds Care for Cancer: Supporting Survivors' Challenge.
    For complete details on the three finalists voted up by an impartial panel of judges including Dr RIchard Just, click here.
    For a recent blog post on JustOncology.com describing the Challenge finalists, click here.
    Meanwhile join us live or via archived replay of this session with Bill Guthrie here.

  • 00:31

    This Week in Oncology

    in Health

    On the Tuesday June 28th broadcast at 8PM Pacific/11PM Eastern, we'll discuss current topics in cancer care.
    For more information on Dr. Just, visit Just Oncology, the blog.
    We'll be broadcasting weekly discussing a range of topics from the latest in evidence based medicine, phase 1 & 2 clincial research trials, the state of community oncology, innovation in health care delivery and payment, patient engagement via social media, and conversational threads alive and well in various patient communities, and more.

  • 00:33

    This Week in Oncology with Jack Andraka

    in Health

    On the Wednesday, February 20th at 1:30PM Pacific/4:30PM Eastern broadcast we are super stoked to chat with scientist, cancer researcher and mathematician, and did I say High School student Jack Andraka. Andraka is the 2012 Intel Science Fair grand prize winner. He was honored with the Gordon E. Moore Award for his work in developing a new method to detect pancreatic cancer.
    I learned about Jack for the fist time from the FutureMed 2013 livestreaming broadcast on February 5th, 2013, titled 'the future of oncology'.
    May I say, I (as were all in attendance at FutureMed as well as the global audience following via the livestream broadcast) was blown away by his passion, intellect and tenacity. For some background information on Jack, see: Meet Jack Andraka: Mathematician, Scientist, Cancer Researcher.
    Listening to him I immediately thought he would be a treat for our listeners, so I reached out to Jack and he's agreed to be on the show.
    For more on this amazing and inspirational young man, take a peek at the entry at wikipedia: Jack Andraka.
    His story of determination in the face of 199 academic rejections, and one tepid, 'we'll see' what you got reception frames focus and passion in a way that many do not experience. 
    Tune in for what will be an informative and fun session.

  • 00:31

    Veterinary Oncology 101 for New Tripawd Pawrents

    in Pets

    Steve Shaw, DVM, DACVIM (Oncology)
    Northern California's Sage Centers for Veterinary Specialty and Emergency Care

    Join Tripawd Talk Radio as Dr. Shaw helps us cover the basics of veterinary oncology for pets with cancer. We'll take away the mysteries surrounding oncology treatment and discuss important things like:

    How do vet oncologists decide on chemotherapy treatments for their patients?
    What if I have different chemotherapy treatments to choose from? How do I decide which one to use?
    Does chemo hurt? Will my pet get sick? What happens if she/he does? Is there anything I can do to avoid that?
    Is there any way to cut the costs of chemo?
    Are there any foods or supplements to avoid during chemo? If so, why?
    What's your take on holistic alternatives to chemotherapy?
    What is the one thing that you wish pet parents would understand about chemo?"

    All this and more on Sunday June 14, 2015! Please join us in the Tripawds Live Chat during the show or call in with your questions.

  • 00:40

    Immuno-Oncology: Exploring the Challenges & Potential

    in Science

    The last 30 years of Immuno-Oncology research have provided strong evidence that tumors do recognize the immune system and their development can be stopped or controlled long term.

    Given the impressive survival data over the past five years, it is not surprising that Immuno-Oncology is arguably the most exciting area in the advancement of science and patient care today.  However, with all research, there are plenty of challenges and to get a better understanding of this innovative approach to cancer research, we are pleased to welcome to the program, James Gulley, MD, PhD of the National Cancer Institute and Roy Baynes, MD, PhD at Merck Research Labs. Joining Drs Gulley and Baynes is Kate Woda, Director of the IO360 conference taking place at Columbia University Faculty House on June 29-30 in NYC.


    Valerie Bowling, Producer, Pharma Talk Radio


    James Gulley, MD, PhD, Head, Immunotherapy Section, Director, Medical Oncology Service, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute

    Roy Baynes, MD, PhD, Senior Vice President, Global Clinical Development, Merck Research Labs

    Kate Woda, Director, IO 360

  • 00:33

    This Week in Oncology with Eduardo Beruff

    in Health

    On the Wednesday, June 13th broadcast at 5PM Eastern/2PM Pacific our special guest is Eduardo Beruff, Chief Executive Officer of Eviti. For complete company details click here.
    Meanwhile, direct from their website:
    'eviti is transforming the cancer treatment decision process with its innovative oncology platform called eviti Suite. Developed through a unique collaboration of leading oncologists, actuaries, insurance professionals and software engineers, eviti is pioneering the way to bring positive solutions to the cancer crisis by empowering physicians with advanced oncology decision support and payers with real-time automated precertification, aligning quality care with the appropriate reimbursement.'   Gregg Masters covered the Wireless Life-Sciences Alliance Convergence Summit in San Diego last month, and Mr. Beruff gave an impressive presentation on the Eviti value proposition and it's fit into the changing medical oncology market place.   We'll chat with Mr. Beruff about his company, it's history, products and services and principal deliverables for its target customers.   To learn more, join us!

  • 00:33

    This Week in Oncology with Linda Bosserman, MD

    in Health

    On the Wednesday, December 12th, 2012 broadcast at 1:30PM Pacific/4:30PM Eastern our special guest is Linda Bosserman, MD, FACP, and President of Wilshire Oncology, see complete bio here.
    It took a while, but we finally snagged this dyanamo in community oncology with a passion for the oncology medical home. We'll discuss the oncology medical home and implications for oncology ACOs.
    Dr Bosserman received her medical degree, completed internship and residency in internal medicine and served on the faculty at Stanford University. This was followed by oncology fellowships and faculty appointments at Harvard Medical School, Dana-Faber Cancer Institute and Brigham and Women's Hospital.  She returned home to southern California where she has been a community medical oncologist at Wilshire Oncology since 1990.
    Women's cancer care, cancer prevention, clinical trials and quality cancer care delivery in community practice are Dr. Bosserman's primary areas of interest.  While Medical Director of the Robert and Beverly Lewis Family Cancer Care Center in Pomona California, she pioneered an integrated psychosocial oncology program and established the Breast Health Center for diagnostic services.  She also directed the Comprehensive Breast Health Task Force, a multidisciplinary community coalition to evaluate and promote high quality, coordinated breast health for the diverse and multicultural residents of the Inland and Pomona Valleys.  She now serves as the medical director of Breast Health at San Antonio Community Hospital.
    Join us for an informative session.

  • 00:44

    This Week in Oncology with Jeff Hall, Ph.D.

    in Health

    On the Wednesday, January 23rd 2013 broadcast our guest is Dr. Jeff Hall, Ph.D. Vice President of Cell Biology at GenOptix. Dr. Hall is making an encore apperance on This Week in Oncology (TWiO). Learn more about GenOptix here.
    Topic: Biomarkers their emerging clinical significance in the diagnosis and treatment of cancer.
    With over 20 years of experience in the life sciences industry, Jeff Hall, PhD is currently the Vice President of Clinical Education at Genoptix, a division of Novartis. He spends most of his time interacting with physicians, working to get Genoptix’ cutting edge hematopathology services  in the hands of the oncologists and pathologists whose patients will benefit from the state of the art testing services and reports which  Genoptix offers.    Dr. Hall holds a B.A. in Biology and Chemistry from U.C. Santa Cruz and a Ph.D. in Biochemistry from U.C. Berkeley.  Dr Hall was the first author on the landmark 1990 Science paper describing the location of BRCA I on chromosome 17q. Prior to joining Genoptix, Dr. Hall was Vice President of Genomics at PPGx in La Jolla. While there, he was responsible for running three laboratory genetics groups in the United States and Europe. Dr. Hall also worked at Axys Pharmaceuticals in 1998 as Senior Director of Genomics and from 1996 to 1997 at Sequana Therapeutics as Director of Genetics. From 1992 to 1995 Dr. Hall was the Director of Genetics at CellPro.
    Join us!

  • 01:30

    Naturopathic Oncology and Mitochonduial Health. Meet Dr. Nasha Winters !

    in Health

    Cancer!!! Are there options in the Alternative Care Arena??

    On Monday, 1/18/16 at 8PM eastern, Dr. Jess Armine has the honor of interviewing Dr. Nasha Winters. Nasha Winters, ND, L.Ac, Dipl.OM, FABNO completed her training in Acupuncture and Oriental Medicine from International Institute of Chinese Medicine in Albuquerque, NM 2000 and her Doctorate in Naturopathic Medicine from Southwest College of Naturopathic Medicine and Health Sciences in Tempe, AZ in 2003 and is board certified and licensed in both. 

    Dr. Nasha Winters approaches each client she has the privilege to meet with fresh eyes and an open heart, acknowledging the infinite, biochemically individual being before her.  The concept of “Personalized Medicine” is just taking root in western medicine though Dr. Winters has never deviated from this concept in nearly 25 years of working in the health care industry.

    Unlike the standard of care methods of clinical oncology, Dr. Nasha focuses on treating the whole person. The tools in her tool box focus on supporting the healthy cells, increasing the effectiveness of conventional treatments, preventing chemo-resistance, helping one stay on schedule with the treatments, and treating the sometimes awful side effects one may endure. Her job continues long after the debulking process is complete. She is there to help the body heal from the treatments, investigate the underlying cause of the cancer, and implement a diet and lifestyle that aims to prevent recurrence. Dr. Nasha loves educating the masses with particular focus on mitochondrial health and function from the abstract to the concrete by blending ancient wisdom with modern science to bring individuals back to optimal health in mind, body and spirit.

    Her website is: www.optimalterrainconsulting.com